Form 4: Director Michael P. Bailey Receives Verastem Equity Grant
Director Equity Grant
Director Michael P. Bailey was granted 108,000 restricted stock units in Verastem, Inc. as part of an equity incentive plan.
Summary
- Director Michael P. Bailey received a total of 108,000 restricted stock units (RSUs) from Verastem, Inc. on May 21, 2026.
- The grant consists of 36,000 Annual Grant RSUs and 72,000 Initial Grant RSUs.
- The Annual Grant RSUs vest in twelve installments through May 31, 2027.
- The Initial Grant RSUs vest in twelve quarterly installments over a three-year period starting from May 21, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
Negatives
- Potential for future shareholder dilution upon the vesting and issuance of the underlying common stock.
Risks
- Vesting is contingent upon the continued service of the director, creating a dependency on personnel retention.
Future Outlook
The director's equity will vest over the next three years, contingent upon continued service to the company.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practice in the biotechnology sector to ensure long-term alignment between board members and company performance.
Comparison to Industry Standards
- The use of the 2021 Equity Incentive Plan is consistent with standard compensation structures for mid-cap biotechnology firms.
- Vesting schedules tied to continued service are typical for board-level equity compensation.
Stakeholder Impact
- Shareholders may experience minor dilution as these RSUs vest and convert into common stock.
Next Steps
- Vesting of Annual Grant RSUs beginning June 2026.
- Vesting of Initial Grant RSUs on a quarterly basis starting three months after May 21, 2026.
Key Dates
| Date | Description |
|---|---|
| 05/21/2026 | Date of the equity grant transaction. |
| 05/27/2026 | Date the Form 4 was signed and filed. |
Keywords
Verastem, VSTM, Form 4, Director Compensation, Equity Incentive Plan, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.